Osprey Medical's (ASX:OSP) Limb Recovery System reduced bacterial load in patients with diabetic foot infections during a pilot trial - so much so that one patient escaped the need for amputation. [ + ]

Biotech and medtech leaders are participating this week and next in focus groups to share their views and perspectives on industry policy and bolster the 2014 Biotechnology Industry Position Survey, due for release in May. [ + ]

The skull reconstruction of an extinct carnivorous marsupial suggests it had the ability to hunt prey much larger than itself. [ + ]

Researchers from La Trobe University have found that the natural defence mechanisms of a tobacco plant could be harnessed to kill cancer cells in the human body. [ + ]

Avita Medical (ASX:AVH) announced the EU launch of a version of its ReCell Spray-on Skin that eliminates the requirement for refrigeration, but the new version is not yet approved in Australia. [ + ]

Minomic International has tapped CUSP Group to help conduct two US trials of MiSat, a prostate cancer screening tool which has shown signs of being more accurate than the standard PSA test. [ + ]

Physicists from the University of Otago have developed a steerable 'optical tweezers' unit that uses intense laser beams to precisely split minute clouds of ultracold atoms and to smash them together. [ + ]

A biochemical signal involved in driving mucosal immune cells into action against bacteria and fungi has been uncovered. [ + ]

Oil and gas companies Chevron and Woodside, alongside The University of Western Australia (UWA), are launching an international search for an expert who can breathe new life into the discipline of palynology in Western Australia. [ + ]

Viralytics (ASX:VLA) announced that its Cavatak cancer treatment showed signs of oncolytic activity during a phase II trial, and of synergy with a new class of cancer therapy during lab tests. [ + ]

Melbourne-based biotech company Starpharma has signed an expanded agreement with biopharma company AstraZeneca in the field of cancer medicine. The new agreement will see the application of Starpharma's dendrimer technology to a cancer drug from AstraZeneca's pipeline. [ + ]

CSIRO's chief executive, Dr Megan Clark, has provided an update into new operating arrangements at the organisation. The changes are aimed at making things easier for both staff and those doing business with CSIRO. [ + ]

Hong Kong's 'Soft-landing Programme for Technology and Innovation Collaboration' is open to technology transfer offices (TTOs), research and development centres, research institutes and spin-out companies of overseas universities interested in exploring the Asian market, especially mainland China. [ + ]

Regeneus (ASX:RGS) has selected Hennessy Research to manufacture its canine cancer immunotherapy Kvax for the marketing trials and product launch in the US. [ + ]

Reva sticks to expediting its biodegradable stent Fantom to the clinic. [ + ]